Editorial: Insights in cardiovascular and smooth muscle pharmacology: 2023

Editorial: Insights in cardiovascular and smooth muscle pharmacology: 2023

Saved in:

Bibliographic Details
Main Authors:	Sönke Schildt, Daniel Reichart, Simon Lebek
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Pharmacology
Subjects:	cardiovascular disease heart failure arrhythmias translational medicine pharmacology
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1544594/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Translational advances in cardiovascular therapy: from bench to bedside
by: Sang-Bing Ong, et al.
Published: (2025-07-01)

Cardiovascular Pharmacology: Contemporary Physiologic and Scientific Approaches to Cardiovascular Disease Prevention and Treatment
by: James B. Young, et al.
Published: (2022-12-01)

Pharmacological Management of Supraventricular Tachyarrhythmia in Right Atrial Enlargement Due to Pulmonary Hypertension: Case Series
by: Mochamad Rizky Hendiperdana
Published: (2025-07-01)

Editorial: Emerging trends in cardiac and skeletal muscle pharmacotherapy
by: Young Hoon Son, et al.
Published: (2025-05-01)

Editorial: Advanced therapeutic strategies and safety profiles in heart failure with reduced ejection fraction: contextualizing recent findings
by: Maria del Carmen Asensio-Lopez, et al.
Published: (2025-04-01)

2018 ESC Guidelines for themanagement of cardiovascular diseases during pregnancy (text is available in electronic version doi:10.15829/1560-4071-2019-6-151-228)
by: Article Editorial
Published: (2019-07-01)

Antiarrhythmic and Hemodynamic Effects of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Diseases
by: A. N. Zakirova, et al.
Published: (2022-05-01)

Myocardial <i>DYRK1B</i> Expression Is Increased in Patients with Impaired Cardiac Contractility and Sleep-Disordered Breathing
by: Fatma Bayram, et al.
Published: (2025-01-01)

OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES
by: A. V. Govorin, et al.
Published: (2015-12-01)

NON-PHARMACOLOGICAL INTERVENTIONS IN HEART FAILURE PATIENTS TO IMPROVE SLEEP QUALITY
by: Rosiah Rosiah
Published: (2022-05-01)

HEART RATE VARIABILITY AND ARRHYTHMIAS IN PATIENTS WITH END STAGE CHRONIC RENAL FAILURE ON PROGRAMMED HEMODIALYSIS
by: H. H. Shugushev, et al.
Published: (2003-08-01)

Frequency of arrythmia depending on the severity of the functional class in patients with metabolic syndrome and heart failure
by: D. K. Kurbanova, et al.
Published: (2022-03-01)

Editorial: Mendelian randomization and cardiovascular remodeling
by: Jianxin Qiang, et al.
Published: (2025-03-01)

Future Impact of mRNA Therapy on Cardiovascular Diseases
by: John P. Cooke, et al.
Published: (2022-12-01)

SLEEP APNOEA SYNDROME AND CARDIOVASCULAR DISEASE: A MODERN VIEW
by: I. G. Gordeev, et al.
Published: (2012-12-01)

Editorial: Women in renal pharmacology 2023
by: Nuria Lloberas, et al.
Published: (2025-01-01)

Eurasian guidelines for the prevention and treatment of cardiovascular diseases in patients with obesity (2022)
by: I. E. Chazova, et al.
Published: (2022-10-01)

How to prevent recurrence of atrial fibrillation after catheter ablation
by: Naoya Kataoka, et al.
Published: (2024-02-01)

Predicting Ventricular Tachyarrhythmias in Patients With Left Ventricular Ejection Fraction Improvement Following Cardiac Resynchronization Therapy
by: Adam Visca, et al.
Published: (2025-05-01)

Editorial: Commercialization and industrialization in experimental pharmacology and drug discovery: 2023
by: Sirajudheen Anwar, et al.
Published: (2024-12-01)

Editorial: Reviews in experimental pharmacology and drug discovery 2023: pharmacological management of non-communicable diseases
by: Ali Sharif, et al.
Published: (2025-04-01)

Natriuresis as a Way to Assess the Effectiveness of Diuretic Therapy for Acute Decompensated Heart Failure: Data from a Pilot Study
by: K. V. Charaya, et al.
Published: (2023-01-01)

Double Duty: SGLT2 Inhibitors as Cardioprotective and Anticancer Allies
by: Linda Piras, et al.
Published: (2024-11-01)

Taurine effects on the occurrence of cardiac arrhythmias and QT interval dispersion in patients with postinfarction cardiosclerosis and chronic heart failure: a comparative randomised study
by: I. G. Gordeev, et al.
Published: (2012-02-01)

CLINICAL AND HEMODYNAMIC INTERRELATIONS OF ARRHYTHMIA COURSE IN CHILDREN OF 0 TO 7 YEARS OLD
by: L. I. Svintsova, et al.
Published: (2014-12-01)

Editorial: Frontiers in the midlands society of physiological sciences (2023-2024)
by: Sathish Kumar Natarajan, et al.
Published: (2025-07-01)

Therapeutic potential and mechanistic insights of astragaloside IV in the treatment of arrhythmia: a comprehensive review
by: Meilian Chen, et al.
Published: (2025-04-01)

Integrating network pharmacology and in vivo model to reveal the cardiovascular protective effects of kaempferol-3-O-rutinoside on heart failure
by: Guo Lu-Qin, et al.
Published: (2025-03-01)

Editorial: Model organisms in respiratory pharmacology 2023
by: Alexandra McCarron, et al.
Published: (2025-01-01)

Editorial: Methods in experimental pharmacology 2023
by: Somasundaram Arumugam, et al.
Published: (2025-01-01)

Abstracts of the 2022 Autumn Meeting of the British Society for Cardiovascular Research
by: Carolyn Carr
Published: (2024-08-01)

The Impact of Obesity on Cardiovascular Diseases: Heart Failure
by: Hatem Alansari, et al.
Published: (2025-02-01)

Network pharmacology and experimental study of Angelica sinensis and Astragalus membranaceus capsules in treating heart failure
by: Xue Wu, et al.
Published: (2024-10-01)

Exploring sex-specific clinical features in Chinese patients with Takotsubo syndrome
by: Hong-Yi Duan, et al.
Published: (2025-07-01)

Heart failure and atrial fibrillation: updates and perspectives
by: V. N. Larina, et al.
Published: (2022-08-01)

Incidence and prognostic significance of atrial fibrillation in patients with tako-tsubo syndrome-systematic review and meta-analysis.
by: Andrzej Osiecki, et al.
Published: (2025-06-01)

The Effect of Sacubitril/Valsartan on Supraventricular and Ventricular Arrhythmias in Patients With Heart Failure
by: Alireza Arzhangzadeh, et al.
Published: (2025-05-01)

Silenced SOX2‐OT alleviates ventricular arrhythmia associated with heart failure by inhibiting NLRP3 expression via regulating miR‐2355‐3p
by: Yuming Liang, et al.
Published: (2021-03-01)

Carvedilol therapy effects on structural and electric remodeling in chronic heart failure
by: E. V. Minakov, et al.
Published: (2008-02-01)

Wearable defibrillator to improve accuracy in selecting candidates to implantable defibrillator: A real‐world experience
by: Gabriele Dell'Era, et al.
Published: (2024-12-01)